Navigation Links
GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
Date:10/20/2009

ers, media and other interested parties who wish to tour the Company's new facilities may contact the Company directly at 678-384-7220 (after November 3) to schedule an appointment.

HIV/AIDS Background

HIV affects the entire globe and comes in a variety of subtypes. Clade B is the predominant subtype in North America where there are roughly 60,000 new infections each year. Globally, there are about 2.5 million AIDS infections per year, most primarily involving subtypes AG, B, and C. In 2007, UNAIDS reported 1.3 million people living with AIDS in North America and 33.2 million people living with AIDS worldwide. Presently, there is little to prevent HIV transmission other than education, circumcision, and condoms. It is obvious from the spread of the disease that these methods are not adequate. Existing treatments for individuals infected with HIV include anti-retroviral therapies that are effective but have serious medical side effects and are very expensive (upwards of $1,500/month). This cost is borne primarily by the individual and sometimes by third party insurance, local healthcare, federal or world health organizations. Development and distribution of an effective HIV/AIDS vaccine holds great promise. The GeoVax Vaccine would cost a fraction of the cost of current treatments and, to date, has not elicited serious adverse side effects in several human trials. A population vaccinated with an effective HIV-1 vaccine would be expected to significantly decrease the prevalence of AIDS over time.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prev
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
2. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
3. GeoVax Labs Requests pre-IND Meeting With FDA
4. GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
5. GeoVax Labs, Inc. Provides Clinical Studies Update
6. GeoVax Labs, Inc. Announces Resignation of Director
7. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
8. GeoVax to Exhibit at the 2009 BIO International Convention
9. GeoVax Labs, Inc. Announces First Quarter Financial Results
10. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
11. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... The Conference Forum announced ... Advance Clinical Trials conference taking place on September 19-20 ... , Disruptive thinkers from Novartis, Pfizer, Eli Lilly, ... approaches to reduce expensive infrastructure, engage patients and generate ... be big, or novel, or it must change the ...
(Date:5/22/2013)... Genedata, a leading provider of ... and life science research, today announced AB Enzymes ... its bioinformatics platform for strain genome data management ... AB Enzymes, one of the world’s oldest and ... Genedata Selector accompanied by bioinformatics consulting services. Genedata ...
(Date:5/22/2013)... Alton Housing Authority was hit by bed bugs. ... that their presence has already caused the company $35,000 for ... big spending, My Cleaning Products shared a way how ... in the report that to clear the infestation , ... its employees also attended a mandatory training on bed bugs, ...
(Date:5/21/2013)... , May 22, 2013 ... drug-only formulation of glycopyrronium bromide designed using Prosonix, particle ... company developing a portfolio of inhaled Respiratory Medicines ... study with PSX1002 that will assess its effect on ... doses in patients with moderate to severe chronic obstructive ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
... BNVI ), a leader in the discovery and development ... and cancer, is scheduled to,present at the Bank of Montreal,s ... Chesterman, SVP and CFO of Bionovo, Inc., will,take place on ... the,Millennium Broadway Hotel in New York City., To access ...
... 28 Carl Marks & Co. LP has partnered,with ... Life Sciences,Focus Fund LP. The partnership also gives Carl ... healthcare hedge funds, and an,increased presence in the healthcare ... highly concentrated portfolios which are,long and short public healthcare ...
... Nabi,Biopharmaceuticals (Nasdaq: NABI ) today announced that ... participate in the BMO,Capital Markets Focus on Healthcare Conference ... Hotel in New York, NY. Dr. Hudson,s,presentation at the ... ET., Dr. Hudson will present a company overview ...
Cached Biology Technology:Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management 2Nabi Biopharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference 2
(Date:5/21/2013)... The concept of "place" is increasingly being considered ... now have a new resource that can help ... have with the places in their lives. ... a new book co-edited by the Pacific Northwest ... a human-centered approach to conservation. The book is ...
(Date:5/21/2013)... class of pharmaceuticals can both prevent and treat Alzheimer,s ... "TSPO ligands," are currently used for certain types of ... ligand in young adult mice when pathology was at ... was quite severe," said lead researcher Christian Pike of ... measures of pathology and improved behavior at both ages." ...
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... inches long, grows on wood, and is shaped like a ... , has been discovered on the African island of Sao ... Mycologia . The mushroom is named after Robert Drewes, ... is described in the July/August issue by Professor Dennis Desjardin ...
... PHILADELPHIA - Psychologists at the University of Pennsylvania ... "Unit Bias," which causes people to ignore vital, obvious ... flaw in the modern, evolved mind and may also ... of weight gain. Researchers who focus on the ...
... 15, 2009) A team of researchers led by Dr. ... biological marker for neovascular age-related macular degeneration (AMD), the leading ... a receptor known as CCR3, shows strong potential as a ... for preventive treatment. The findings were reported in an article ...
Cached Biology News:New species of phallus-shaped mushroom named after California Academy of Sciences scientist 2'Shortcuts' of the mind lead to miscalculations of weight and caloric intake, says Penn study 2'Shortcuts' of the mind lead to miscalculations of weight and caloric intake, says Penn study 3Major breakthrough in early detection and prevention of AMD 2Major breakthrough in early detection and prevention of AMD 3
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
TGF-beta 2 MAb (Clone 8607)...
Fluorescein-CSCSSLMDKECVYFCHLDIIW (Disulfide bridge: 1-15 and 3-11)...
... for isolation and affinity purification of ... peptides. Hydrophobic, monodisperse magnetic particles (2.8 ... groups, further surface activation is not ... with optimal orientation for affinity purification ...
Biology Products: